24,94 No evidence or guidelines advise the use of aspirin for the prevention of atherosclerotic cardiovascular disease in the primary prevention setting for people with high lipoprotein(a); however, ...
First author Professor Børge Nordestgaard, Clinical Professor at the University of Copenhagen and Chief Physician at Copenhagen University Hospital - Herlev-Gentofte Hospital, says, "It's high ...
Five drugs are currently in development that can lower the amount of lipoprotein(a) by 65 to 98 %, three of which are in phase 3 clinical trials. Some of the new medication under development is so ...
If successful, the results from the TANDEM trial could lead to a new treatment option for patients struggling with high cholesterol, particularly those who do not respond to current therapies.
There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing movement disorders while taking an antipsychotic, according to a study ...
Yet most people that carry an increased amount of lipoprotein(a) are unaware. With new medication under way that lowers the amount of the lipid particle significantly, it is high time we identify ...
The proposed mechanisms for the effects of POM3 on the lipoprotein lipid ... LDL-C treatment goal Non-HDL-C treatment goal if TG ≥ 2.26 mmol/l Moderately high risk: 2+ risk factors ¶ (10- ...